Question: is prucalopride available in the us?
Answer: Lexington, MA, April 2, 2019 – Takeda Pharmaceuticals U.S.A., Inc., (“Takeda”) today announced that Motegrity™ (prucalopride), a once-daily, oral treatment option, is now commercially available by prescription in the United States for adults with chronic idiopathic constipation (CIC).